← Human Trials & Peer-Reviewed Studies
Racial/ethnic disparities in magnesium sulfate neuroprotection: a subgroup analysis of a multicenter randomized controlled trial.
Plain-language guide to PMID 28612671 (2018): randomized controlled trial of Vitamin D, K2, Magnesium and Zinc.
Key Facts
- PMID
- 28612671
- Journal
- The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
- Year
- 2018
- Study type
- Randomized Controlled Trial
- Authors
- Vilchez G et al. (6 authors)
- DOI
- 10.1080/14767058.2017.1342795
What This Study Did, in Plain Language
What Was Tested
Researchers studied Vitamin D, K2, Magnesium and Zinc in this randomized controlled trial publication.
The researchers analyze the effect of race/ethnicity in maternal/infant outcomes after MgSO4 neuroprotection.
Who Took Part
The age groups tagged for this paper are young adults and adults, women only.
Subgroup analysis of a multicenter clinical trial (BEAM trial) where pregnant women at risk of preterm birth were randomized to either MgSO4 or placebo.
How the Study Was Run
The researchers set it up as a randomized, placebo-controlled and multicenter study.
Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
The comparison arm used a placebo, so changes seen with Vitamin D, K2, Magnesium and Zinc could be set against what happens without it.
Running at several centres spread the Vitamin D, K2, Magnesium and Zinc study over different clinics and patient groups.
The effect of race in maternal/neonatal outcomes after MgSO4 was analyzed with Breslow-Day and multifactorial ANOVA.
What Was Measured
Topics PubMed links to this paper include Drug-Related Side Effects and Adverse Reactions, Ethnicity, Magnesium Sulfate, Neuroprotection, Pregnancy Outcome, Premature Birth and Racial Groups.
Author keywords: Adverse effects, continental population groups, ethnic groups and pregnancy complications.
What This Means in Plain Language
The paper is a randomized, placebo-controlled and multicenter study of Vitamin D, K2, Magnesium and Zinc.
Its findings take up roughly 5 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2018 (The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians), a journal based in England.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.